GF
RVPHW

Gabelli Funds’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Gabelli Funds’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89,921
Closed -$61K – 1345
2020
Q4 		$61K Sell
89,921
-28,279
-24% -$15.5K ﹤0.01% 1185
2020
Q3 		$60K Hold
118,200
– – ﹤0.01% 1097
2020
Q2 		$56K Hold
118,200
– – ﹤0.01% 1034
2020
Q1 		$11K Hold
118,200
– – ﹤0.01% 1070
2019
Q4 		$30K Hold
118,200
– – ﹤0.01% 1087
2019
Q3 		$30K Hold
118,200
– – ﹤0.01% 1110
2019
Q2 		$25K Hold
118,200
– – ﹤0.01% 1147
2019
Q1 		$19K Buy
+118,200
New +$23.4K ﹤0.01% 1133

Other funds holding RVPHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Gabelli Funds's RVPHW Position: Q1 2021 in Review

Gabelli Funds sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q1 2021, closing a stake of 89,921 shares — an estimated $61K sold.

Gabelli Funds first reported a position in RVPHW in Q1 2019 and held it in 8 quarters. The position peaked at $61K in Q4 2020. 12 funds tracked by Wall St. Rank hold RVPHW as of Q1 2021.

  • Gabelli Funds reported no remaining Reviva Pharmaceuticals Warrants position as of Q1 2021 after selling out during the quarter.
  • Gabelli Funds sold 89,921 Reviva Pharmaceuticals Warrants shares in Q1 2021, an estimated $61K.
  • Gabelli Funds first reported a position in Reviva Pharmaceuticals Warrants in Q1 2019 and held it in 8 quarters.
  • Gabelli Funds's Reviva Pharmaceuticals Warrants position peaked at $61K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.